🇺🇸 FDA
Patent

US 9586925

1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia

granted A61PA61P25/28

Quick answer

US patent 9586925 (1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia) held by NOBEL ILAÇ SANAYII VE TICARET A.S. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NOBEL ILAÇ SANAYII VE TICARET A.S.
Grant date
Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/28